Association between periodontal disease and osteoporosis in postmenopausal women: a protocol for systematic review and meta-analysis

Código QR

Association between periodontal disease and osteoporosis in postmenopausal women: a protocol for systematic review and meta-analysis

Guardado en:

Detalles Bibliográficos
Autores principales:	Jing Qi, Yu-Ting Liu, Guang Chen, E Liu, Yu-Feng Guo, Jie-Mei Hu, Hai-Quan Yue
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/01f2eacff2bd456a9cab245a5cce7c78
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Primary osteoporosis in postmenopausal women
por: Meng-Xia Ji, et al.
Publicado: (2015)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Hisaya Kawate, et al.
Publicado: (2010)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara S, et al.
Publicado: (2014)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
por: Philip Sambrook
Publicado: (2007)

No Association between Metabolic Syndrome and Periodontitis in Korean Postmenopausal Women
por: Jeong-In Kim, et al.
Publicado: (2021)

Retraction Note: Associations between VDR Gene Polymorphisms and Osteoporosis Risk and Bone Mineral Density in Postmenopausal Women: A systematic review and Meta-Analysis
por: Liang Zhang, et al.
Publicado: (2021)

Serum interleukin-17 and estradiol levels in postmenopausal women in relation to osteoporosis
por: Reem El-Mallah, et al.
Publicado: (2021)

Assessment of periodontal status in pre- and postmenopausal women with chronic periodontitis: A cross-sectional study
por: Richa Agrawal, et al.
Publicado: (2021)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate H, et al.
Publicado: (2011)

Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures
por: Ciubean AD, et al.
Publicado: (2018)

Prevalence and Risk Factors of Osteoporosis in Chinese Postmenopausal Women Awaiting Total Knee Arthroplasty
por: Tao Y, et al.
Publicado: (2021)

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Luigi Gennari, et al.
Publicado: (2010)

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
por: Esteban Jódar-Gimeno
Publicado: (2007)

The importance of the UGT1A1 variants in the development of osteopenia and osteoporosis in postmenopausal women
por: Anna Bogacz, et al.
Publicado: (2021)

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
por: Jun Iwamoto, et al.
Publicado: (2008)

Denosumab: an investigational drug for the management of postmenopausal osteoporosis
por: E Michael Lewiecki
Publicado: (2008)

Denosumab versus romosozumab for postmenopausal osteoporosis treatment
por: Tomonori Kobayakawa, et al.
Publicado: (2021)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Piet Geusens
Publicado: (2009)

Patterns of Migraine in Postmenopausal Women: A Systematic Review
por: Ornello R, et al.
Publicado: (2021)

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu H, et al.
Publicado: (2019)

BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women
por: Ma Z, et al.
Publicado: (2016)

WGCNA Identification of Genes and Pathways Involved in the Pathogenesis of Postmenopausal Osteoporosis
por: Hao ML, et al.
Publicado: (2021)

Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?
por: Peker N, et al.
Publicado: (2018)

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
por: Baccaro LF, et al.
Publicado: (2015)

Asociación entre osteoporosis y periodontitis crónica
por: Navarrete,Mariely, et al.
Publicado: (2016)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Oliver Bock, et al.
Publicado: (2008)

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
por: John Sunyecz
Publicado: (2008)

Diagnosis of Presarcopenia Using Body Height and Arm Span for Postmenopausal Osteoporosis
por: Ono Y, et al.
Publicado: (2020)

The predictive role of monocyte-lymphocyte ratio and plateletlymphocyte ratio in postmenopausal osteoporosis
por: Ibrahim Kale
Publicado: (2021)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
por: Federica Bellone, et al.
Publicado: (2021)

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
por: Liu Z, et al.
Publicado: (2020)

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial
por: Jiang Y, et al.
Publicado: (2014)

Short-range UV-LED irradiation in postmenopausal osteoporosis using ovariectomized mice
por: Satoshi Ochiai, et al.
Publicado: (2021)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
por: María J Moro-Álvarez, et al.
Publicado: (2008)

Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study
por: Fan T, et al.
Publicado: (2013)

Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
por: Masashi Uehara, et al.
Publicado: (2021)

Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women.
por: Zhao-min Liu, et al.
Publicado: (2014)

Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model
por: Hongxia Zhao, et al.
Publicado: (2018)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009)

Exploring the Effect of Jiawei Buguzhi Pills on TGF-β-Smad Pathway in Postmenopausal Osteoporosis Based on Integrated Pharmacological Strategy
por: Xiao Yuan, et al.
Publicado: (2021)